---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-23-000014"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2023-02-07T23:59:59+00:00"
generated_at: "2026-06-19T22:55:11.061439+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical posts first profitable quarter; Q4 revenue $137.9M (+76% YoY) and guides FY2023 $560-570M

## Summary
- Q4 2022 net income $3.2M, diluted EPS $0.10, vs. loss of $2.4M in Q4 2021.
- Q4 revenue $137.9M (76% YoY); U.S. revenue $134.3M (+78%), OUS revenue $3.6M (+28%).
- Gross margin 83.9% in Q4, down from 85.8% due to inflation and supply chain costs.
- Full year 2022 revenue $407.9M (+75% YoY); net loss $44.9M vs. $42.0M in 2021.
- FY2023 revenue guidance $560-570M (37-40% growth); expects to add 52-56 new U.S. centers per quarter.

## SEC filing metadata
- accession: 0001609550-23-000014
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2023-02-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955023000014/0001609550-23-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955023000014/insp-20230207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-23-000014
- JSON: https://secwatch.observer/filing/0001609550-23-000014.json
- Plain text: https://secwatch.observer/filing/0001609550-23-000014.txt

## Key facts
- Earnings Releases
  Inspire Medical Systems, Inc. reported full year 2023 results: revenue $560 million to $570 million. Guidance initiated.
  - Period: full year 2023
  - Revenue: $560 million to $570 million
  - Guidance: initiated
  - Result: guidance update
  source text: Inspire expects full year 2023 revenue to be in the range of $560 million to $570 million, which would represent growth of approximately 37% to 40% over full year 2022 revenue of $407.9 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955023000014/0001609550-23-000014-index.htm
- Earnings Releases
  Inspire Medical Systems, Inc. reported the fiscal year ended December 31, 2022 results: revenue $407.9 million, net income $44.9 million, EPS $1.60.
  - Period: the fiscal year ended December 31, 2022
  - Revenue: $407.9 million
  - Net income: $44.9 million
  - EPS: $1.60
  - Result: reported results
  source text: Highlights and Full Year 2023 Guidance • Generated revenue of $137.9 million in the fourth quarter of 2022, a 76% increase over the same quarter last year, and revenue of $407.9 million in full year 2022, a 75% increase over full year 2021 • Achieved gross margin of 83.9% in the fourth quarter of 2022 • Reported net income of $3.2 million and diluted net
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955023000014/0001609550-23-000014-index.htm
- Earnings Releases
  Inspire Medical Systems, Inc. reported the quarter ended December 31, 2022 results: revenue $137.9 million, net income $3.2 million, EPS $0.10.
  - Period: the quarter ended December 31, 2022
  - Revenue: $137.9 million
  - Net income: $3.2 million
  - EPS: $0.10
  - Result: reported results
  source text: Revenue was $137.9 million for the three months ended December 31, 2022, a 76% increase from $78.4 million in the corresponding period in the prior year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955023000014/0001609550-23-000014-index.htm
- Earnings Releases
  Inspire Medical Systems, Inc. updated its the quarter and fiscal year ended December 31, 2022 guidance (reaffirmed).
  - Period: the quarter and fiscal year ended December 31, 2022
  - Guidance: reaffirmed
  - Result: reported results
  source text: On February 7, 2023, Inspire Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955023000014/0001609550-23-000014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.